Inhibition of GLUD1 mediated by LASP1 and SYVN1 contributes to hepatitis B virus X protein-induced hepatocarcinogenesis
Journal of Molecular Cell Biology · 30.09.2024 · 16 (4)
DOI: 10.1093/jmcb/mjae014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, online erschienen am 08.04.2024. Verfasst von Hong-Juan You und 12 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou 221004, China. Hauptthemen laut MEDLINE: LIM Domain Proteins, Liver Neoplasms, Glutamate Dehydrogenase, Cytoskeletal Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Natural Science Foundation of the Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
Glutamate dehydrogenase 1 (GLUD1) is implicated in oncogenesis. However, little is known about the relationship between GLUD1 and hepatocellular carcinoma (HCC). In the present study, we demonstrated that the expression levels of GLUD1 significantly decreased in tumors, which was relevant to the poor prognosis of HCC. Functionally, GLUD1 silencing enhanced the growth and migration of HCC cells. Mechanistically, the upregulation of interleukin-32 through AKT activation contributes to GLUD1 silencing-facilitated hepatocarcinogenesis. The interaction between GLUD1 and AKT, as well as α-ketoglutarate regulated by GLUD1, can suppress AKT activation. In addition, LIM and SH3 protein 1 (LASP1) interacts with GLUD1 and induces GLUD1 degradation via the ubiquitin–proteasome pathway, which relies on the E3 ubiquitin ligase synoviolin (SYVN1), whose interaction with GLUD1 is enhanced by LASP1. In hepatitis B virus (HBV)-related HCC, the HBV X protein (HBX) can suppress GLUD1 with the participation of LASP1 and SYVN1. Collectively, our data suggest that GLUD1 silencing is significantly associated with HCC development, and LASP1 and SYVN1 mediate the inhibition of GLUD1 in HCC, especially in HBV-related tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou 221004, China.
- Laboratory Department, The People's Hospital of Funing, Yancheng 224400, China.
- National Demonstration Center for Experimental Basic Medical Sciences Education, Xuzhou Medical University, Xuzhou 221004, China.
ORCID-Profile: Ren-Xian Tang
Förderung
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Natural Science Foundation of the Jiangsu Higher Education Institutions
Zitieren
APA
You, H. J., Li, Q., Ma, L. H., Wang, X., Zhang, H. Y., Wang, Y. X., Bao, E. S., Zhong, Y. J., Kong, D. L., Liu, X. Y., Kong, F. Y., Zheng, K. Y., & Tang, R. X. (2024). Inhibition of GLUD1 mediated by LASP1 and SYVN1 contributes to hepatitis B virus X protein-induced hepatocarcinogenesis. Journal of Molecular Cell Biology, 16(4). https://doi.org/10.1093/jmcb/mjae014
Vancouver
You HJ, Li Q, Ma LH, Wang X, Zhang HY, Wang YX, et al. Inhibition of GLUD1 mediated by LASP1 and SYVN1 contributes to hepatitis B virus X protein-induced hepatocarcinogenesis. Journal of Molecular Cell Biology. 2024;16(4). doi:10.1093/jmcb/mjae014
BibTeX
@article{You2024,
author = {You, Hong-Juan and Li, Qi and Ma, Li-Hong and Wang, Xing and Zhang, Huan-Yang and Wang, Yu-Xin and Bao, En-Si and Zhong, Yu-Jie and Kong, De-Long and Liu, Xiang-Ye and Kong, Fan-Yun and Zheng, Kui-Yang and Tang, Ren-Xian},
title = {Inhibition of GLUD1 mediated by LASP1 and SYVN1 contributes to hepatitis B virus X protein-induced hepatocarcinogenesis},
journal = {Journal of Molecular Cell Biology},
year = {2024},
volume = {16},
number = {4},
doi = {10.1093/jmcb/mjae014}
}
EUVIMED